Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2017
As of Sep 30, 2016
Q1 FY2017
As of Jun 30, 2016
Q4 FY2016
As of Mar 31, 2016
Q3 FY2016
As of Dec 31, 2015
Q2 FY2016
As of Sep 30, 2015
Q1 FY2016
As of Jun 30, 2015
Q4 FY2015
As of Mar 31, 2015
Q3 FY2015
As of Dec 31, 2014
Q2 FY2015
As of Sep 30, 2014
Q1 FY2015
As of Jun 30, 2014
Q4 FY2014
As of Mar 31, 2014
Q3 FY2014
As of Dec 31, 2013
Q2 FY2014
As of Sep 30, 2013
Q1 FY2014
As of Jun 30, 2013
Q4 FY2013
As of Mar 31, 2013
Q3 FY2013
As of Dec 31, 2012
Q2 FY2013
As of Sep 30, 2012
Q1 FY2013
As of Jun 30, 2012
Q4 FY2012
As of Mar 31, 2012
Q3 FY2012
As of Dec 31, 2011
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Inventories
Assets held for sale
Other current assets
Total current assets
Property and equipment, net
Goodwill
Purchased intangibles, net
Other assets
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
Accrued payroll and other accrued liabilities
Veloce accrued liability
Other accrued liabilities
Deferred revenue
Total current liabilities
Veloce and other non-current liabilities
Non-current liabilities
Total liabilities
Stockholders’ equity:
Preferred stock, $0.01 par value: Authorized shares - 2,000, none issued and outstanding
Issued and outstanding shares - 86,453 at September 30, 2016 and 84,590 at March 31, 2016
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support